Loxo Oncology
Loxo Oncology/Loxo@Lilly, an Eli Lilly company, is a biopharmaceutical company focused on the development and commercialization of highly selective medicines for patients with genomically defined cancers.

Year Established: 2013
Stock Ticker: NYSE
Exchange: LLY